• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Orchid Pharma Limited — Updates, 07-07-2026: Press Release

    07-07-2026 | 07:27 pm

    Orchid Pharma partnered with Pharmasyntez JSC via a licensing and supply agreement for its novel antibiotic, Exblifep®, in Russia. Orchid will supply finished dosage, with Pharmasyntez holding commercialization rights. This presents a potential USD 178 million opportunity over 10 years.

    No comments yet. Be the first to comment!

    All announcements from Orchid Pharma Limited